tiprankstipranks
Trending News
More News >
Invesque (OTC) (TSE:IVQ)
OTHER OTC:IVQ

Invesque (IVQ) AI Stock Analysis

Compare
10 Followers

Top Page

TSE:IVQ

Invesque

(OTC:IVQ)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
C$0.15
▲(16.15% Upside)
The score is held back primarily by weak financial performance (declining revenue, persistent losses, and high leverage with negative cash flows). Technical indicators provide partial offset with a clear short-term uptrend and positive momentum, while valuation remains difficult to support due to negative earnings and no stated dividend yield.
Positive Factors
Strategic Partnerships
Collaborations with established operators enhance operational efficiency and occupancy rates, supporting long-term revenue stability and growth.
Cash Flow Improvement
Improving cash flow growth suggests better liquidity management, enhancing the company's ability to fund operations and investments.
Healthcare Demand
The aging population trend supports long-term demand for healthcare properties, providing a stable growth opportunity for Invesque.
Negative Factors
High Leverage
High leverage limits financial flexibility and increases risk, potentially impacting the company's ability to invest in growth opportunities.
Declining Revenue
A declining revenue trend undermines financial stability and growth prospects, challenging the company's ability to sustain operations.
Negative Profit Margins
Persistent negative profit margins indicate operational inefficiencies, hindering profitability and long-term financial health.

Invesque (IVQ) vs. iShares MSCI Canada ETF (EWC)

Invesque Business Overview & Revenue Model

Company DescriptionInvesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.
How the Company Makes MoneyInvesque generates revenue primarily through rental income from its portfolio of healthcare properties. The company leases its facilities to well-established operators, which pay rent based on long-term lease agreements. Additionally, Invesque may earn income through property management fees and performance-based incentives tied to the operational success of its tenants. The company can also benefit from capital appreciation of its properties and potential sales of assets at a profit. Partnerships with experienced operators in the healthcare sector help ensure steady occupancy rates and revenue stability, contributing significantly to its earnings. Furthermore, Invesque may engage in financing activities, such as issuing equity or debt, to fund acquisitions and optimize its capital structure.

Invesque Financial Statement Overview

Summary
Invesque faces significant financial challenges with declining revenues, negative profitability, high leverage, and weak cash flow generation. These factors suggest potential financial instability.
Income Statement
Invesque's income statement shows declining revenue with a negative growth rate of -9.16% TTM, indicating a challenging market environment. The gross profit margin is relatively stable at 38.17%, but the net profit margin is negative at -24.24%, reflecting ongoing profitability issues. The EBIT margin is low at 2.74%, and EBITDA margin is 9.10%, suggesting limited operational efficiency.
Balance Sheet
The balance sheet reveals a high debt-to-equity ratio of 3.44 TTM, indicating significant leverage and potential financial risk. Return on equity is negative at -33.12%, highlighting unprofitable operations. The equity ratio is not explicitly provided, but the high leverage suggests limited equity relative to assets.
Cash Flow
Cash flow analysis shows a concerning decline in free cash flow growth at -242.34% TTM, and operating cash flow is negative, indicating cash management challenges. The operating cash flow to net income ratio is low at 0.02, and free cash flow to net income ratio is 0.46, reflecting weak cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue109.74M162.67M188.75M198.03M210.45M217.39M
Gross Profit40.26M59.00M72.41M95.59M90.97M108.39M
EBITDA2.06M24.27M-18.83M10.38M49.13M-101.52M
Net Income-32.72M-36.14M-99.24M-42.01M-28.54M-184.00M
Balance Sheet
Total Assets179.94M637.22M828.28M1.10B1.30B1.50B
Cash, Cash Equivalents and Short-Term Investments15.16M18.16M10.74M27.58M19.37M34.13M
Total Debt39.97M394.84M588.25M765.46M893.75M1.05B
Total Liabilities82.40M518.05M681.18M865.69M1.01B1.21B
Stockholders Equity97.54M119.17M146.59M231.65M286.26M293.33M
Cash Flow
Free Cash Flow-12.38M4.40M217.00K5.40M11.11M13.82M
Operating Cash Flow-8.79M9.27M6.03M11.91M18.68M25.09M
Investing Cash Flow420.04M152.21M132.05M137.49M119.19M2.98M
Financing Cash Flow-410.70M-154.07M-154.92M-141.19M-152.63M-5.78M

Invesque Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.13
Price Trends
50DMA
0.12
Positive
100DMA
0.12
Positive
200DMA
0.13
Positive
Market Momentum
MACD
<0.01
Negative
RSI
57.85
Neutral
STOCH
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.12, and below the 200-day MA of 0.13, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 57.85 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IVQ.

Invesque Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
C$1.66B5.8017.29%0.09%10.61%43.64%
66
Neutral
C$32.89M6.704.45%2.31%2.03%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
51
Neutral
C$127.97M-0.87-31.26%-33.25%90.14%
46
Neutral
C$126.42M-11.7410.31%58.15%-235.04%
43
Neutral
C$1.88B-537.50-2.63%0.25%9.98%93.01%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:IVQ
Invesque
0.14
0.02
16.67%
TSE:IEI
Imperial Equities
3.48
-0.29
-7.69%
TSE:MEQ
Mainstreet Equity
179.10
-11.75
-6.16%
TSE:SVI
Storagevault Canada
5.16
1.21
30.63%
TSE:PKT
Parkit Enterprise
0.60
-0.07
-10.45%
TSE:BRE
Bridgemarq Real Estate Services
13.33
-0.06
-0.42%

Invesque Corporate Events

Business Operations and StrategyM&A Transactions
Invesque Sells Nine Seniors Properties, Moves to Redeem US$27.3 Million Debentures
Positive
Dec 29, 2025

Invesque Inc. has accelerated its portfolio restructuring by disposing of nine properties in December, including four U.S. seniors housing assets sold for US$57 million, a medical office building in New York sold for US$4.1 million, and its only Canadian retirement home investment, which generated CAD$31 million of net equity. The company is using proceeds from a year of heavy asset sales—46 assets sold for more than US$550 million and roughly US$510 million of debt repaid—to redeem in early 2026 all US$27.3 million of its 9.75% unsecured subordinated debentures, a move that further deleverages its balance sheet and leaves Invesque with a streamlined portfolio of seven senior housing communities across four U.S. states.

The most recent analyst rating on (TSE:IVQ) stock is a Hold with a C$0.11 price target. To see the full list of analyst forecasts on Invesque stock, see the TSE:IVQ Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Invesque Inc. Reports Strategic Asset Sales and Debt Reduction in Q3 2025
Neutral
Nov 7, 2025

Invesque Inc. reported its third-quarter 2025 results, highlighting significant asset sales and debt reduction. The company sold 15 properties, including senior housing and skilled nursing facilities, generating proceeds used to repay substantial debts, including the full repayment of the KeyBank corporate credit facility. This strategic move aligns with Invesque’s disposition and de-leveraging strategy, providing greater financial flexibility and positioning the company for future growth. Despite a decrease in revenue and a net loss, the company’s actions suggest a focus on stabilizing operations and improving financial health.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026